Downloads
-
Biologics Discovery
5/28/2026
Make the most of your molecule with integrated antibody discovery, engineering, and production capabilities designed to accelerate lead identification and optimization.
-
Antibody Discovery And Engineering
5/28/2026
The Antibody Center at Curia provides end-to-end services in antibody discovery, engineering, and development.
-
Molecular Biology
5/28/2026
Our Biologics services provide comprehensive Molecular Biology services at facilities in California and Massachusetts, offering a variety of services.
-
Recombinant Protein Production
5/28/2026
Curia has decades of experience in recombinant protein production.
-
Small Molecules Discovery
5/28/2026
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
Custom Synthesis Services
5/28/2026
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
-
Integrated Stability Workflows That Reduce Manual Data Handling
5/28/2026
Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.
-
Workflow For Chemical Characterization And Database Curation
5/28/2026
Confident identification of known and unknown compounds starts with smarter LC/MS and GC/MS workflows. Learn how structure elucidation, verification, and centralized data curation work together.
-
Improving pKa Prediction Accuracy For PROTACs
5/28/2026
Gain insight into how localized modeling of ionizable centers, supported by curated experimental data, delivers reliable predictions that strengthen physicochemical decision-making.
-
Property-Based Optimization Of Pharmaceutical Lead Compounds
5/28/2026
Property-driven optimization helps medicinal chemists focus synthetic effort where it matters most. See how integrating ADME and physicochemical predictions can surface better-balanced lead candidates.